insights_auto
Why is KROS down 2.82%?
Dive Deeperchevron_right
KROS:NASDAQ
Keros Therapeutics Inc
$11.04
arrow_downward
-2.82%(-0.32) 1D
Oct 30, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KROS...
Open
$11.32
High
$11.49
Low
$10.98
Mkt. cap
218.89M
Avg. vol.
175.87K
Volume
120.16K
52-wk high
$22.55
52-wk low
$9.69
EPS
-$3.70
Beta
1.12
Shares outstanding
19.83M
No. of employees
92
Open
$11.32
High
$11.49
Low
$10.98
Mkt. cap
218.89M
Avg. vol.
175.87K
Volume
120.16K
52-wk high
$22.55
52-wk low
$9.69
EPS
-$3.70
Beta
1.12
Shares outstanding
19.83M
No. of employees
92
News stories
From web sources and news partners
24/7 Wall St.
·
4 hours ago
S&P Says Meta Can’t Make Money From AI as Well as Its Rivals
TradingView
·
6 hours ago
Nifty 500 vs S&P 500: India or US, innovation is the only game in town for investors
BigGo Finance
·
8 hours ago
Nasdaq Plunges 748 Points in a Single Day; Experts Compare to 2000 Bubble: This Time It Hasn't Even Entered Correction Territory
Coinpaper
·
3 hours ago
AI Stocks Lost Billions in October While the Average US Stock Performed Much Better
About Keros Therapeutics Inc
CEO-
Employees92
Founded2015
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitekerostx.com